Overview

Drug Screening Market is poised to value over USD 11.5 billion by 2027 end at a CAGR of over 9.2% during the forecast period 2020 to 2027

There has been a rise in the comsumption of unprescribed drugs and alcohol worldwide. As per the report published by the United Nations Office on Drugs and Crime (UNODC) 2015,  over 5% of the global adult population has at least tried drugs once in their lifetime. Furthermore, over 0.6% of the total adult population across the world suffer from drug abuse disorder. Owing to these statictics, the drug screening market is esimated to showcase substantial growth over the forecasted timeframe.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Drug Screening Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of Drug Screening Market.

According to the research study conducted by FutureWise research analysts, the Drug Screening Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Drug Screening Market are:

• Alere
• Dragerwerk
• Labcorp
• Quest Diagnostics
• Alfa Scientific Designs
• Lifeloc
• MPD Inc.
• Orasure
• Omega Laboratories
• Premier Biotech
• Psychemedics
• Roche
• Shimadzu
• Siemens Healthineers 
• Thermo Fisher Scientific

(Note: The list of the major players will be updated with the latest market scenario and trends)

Drug Screening Market Segmentation:

By Product

• Analytical Instruments
   o Immunoassay Analyzers
   o Chromatography Instruments
   o Breathalyzers
        o Fuel Cell Breathalyzers
        o Semiconductor Breathalyzers
        o Other Breathalyzers
• Rapid Testing Devices
   o Urine Testing Devices
       o Drug Testing Cups
       o DIP Cards
       o Drug Testing Cassettes
   o Oral Fluid Testing Devices
• Consumables
   o Assay Kits
   o Sample Collection Devices
   o Calibrators and Controls
   o Other Consumables

By Drug Screening Services

• Regulated
• Non-Regulated

By Sample Type

• Urine Samples
• Breath Samples
• Oral Fluid Samples
• Hair Samples
• Other Samples

By End-user

• Workplace
• Criminal Justice Systems and Law Enforcement Agencies
• Drug Treatment Centers
• Pain Management Centers
• Schools and Colleges
• Hospitals
• Individual Users
• Drug Testing Laboratories

By Region

• North America
• Latin America
• Europe
• Asia-Pacific
• Rest of the world

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the Drug Screening Market By Product, By Drug Screening Services, By Sample Type, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific and rest of the world
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with the purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com

Table of Contents

1.    Market Introduction

       1.1 Objectives of the Study 
       1.2 Market Definition 
       1.3 Market Scope 
               1.3.1 Years Considered for the Study
               1.3.2 Market Covered
       1.4 Currency 
       1.5 Limitations 
       1.6 Stakeholders 

 2.  Research Methodology 

       2.1 Research Data 
             2.1.1 Secondary Data
                 2.1.1.1 Key Data from Secondary Sources
             2.1.2 Primary Data
                 2.1.2.1 Key Data from Primary Sources
       2.2 Market Size Estimation 
       2.3 Market Breakdown and Data Triangulation 
       2.4 Assumptions for the Study  

3.    Executive Summary

        3.1 Market Outlook
        3.2 Segment Outlook
        3.3 Competitive Insights

4. Global Drug Screening Market Variables, Trends & Scope

       4.1. Market Lineage Outlook
       4.2. Penetration and Growth Prospect Mapping
       4.3. Industry Value Chain Analysis
       4.4. Cost Analysis Breakdown
       4.5. Technology Overview
       4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances

5. Market Overview

     5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus of Medical Device Companies on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Drug Screening Market Analysis Tools

         6.1. Industry Analysis - Porter’s
               6.1.1. Supplier Power
               6.1.2. Buyer Power
               6.1.3. Substitution Threat
               6.1.4. Threat from New Entrants
               6.1.5. Competitive Rivalry
         6.2. Pestel Analysis
               6.2.1. Political Landscape
               6.2.2. Environmental Landscape
               6.2.3. Social Landscape
               6.2.4. Technology Landscape
               6.2.5. Legal Landscape
         6.3. Major Deals And Strategic Alliances Analysis
                6.3.1. Joint Ventures
                6.3.2. Mergers and Acquisitions
                6.3.3. Licensing and Partnership
                6.3.4. Technology Collaborations
                6.3.5. Strategic Divestments
         6.4. Market Entry Strategies
         6.5. Case Studies

7. Global Drug Screening Market, By Product Historical Analysis and Forecast  2020-2027 (USD Million)

           7.1. Analytical Instruments
                7.1.1. Immunoassay Analyzers
                7.1.2. Chromatography Instruments
                7.1.3. Breathalyzers
                       7.1.3.1. Fuel Cell Breathalyzers
                       7.1.3.2. Semiconductor Breathalyzers
                       7.1.3.3. Other Breathalyzers
           7.2. Rapid Testing Devices
               7.2.1. Urine Testing Devices
                      7.2.1.1. Drug Testing Cups
                      7.2.1.2. DIP Cards
                      7.2.1.3. Drug Testing Cassettes
               7.2.2. Oral Fluid Testing Devices  
           7.3. Consumables
               7.3.1. Assay Kits
               7.3.2. Sample Collection Devices
               7.3.3. Calibrators and Controls
               7.3.4. Other Consumables

8. Global Drug Screening Market, By Drug Screening Services Historical Analysis and Forecast 2020-2027 (USD Million)

            8.1. Regulated
            8.2. Non-Regulated

9. Global Drug Screening Market, By Sample Type Historical Analysis and Forecast 2020-2027 (USD Million)

            9.1. Urine Samples
            9.2. Breath Samples
            9.3. Oral Fluid Samples
            9.4. Hair Samples
            9.5. Other Samples

 10. Global Drug Screening Market, By End User Historical Analysis and Forecast  2020-2027 (USD Million)

            10.1. Workplace
            10.2. Criminal Justice Systems and Law Enforcement Agencies
            10.3. Drug Treatment Centers
            10.4. Pain Management Centers
            10.5. Schools and Colleges
            10.6. Hospitals
            10.7. Individual Users
            10.8. Drug Testing Laboratories  
         
11. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

     12.1. Introduction
     12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            12.2.1. U.S.A
            12.2.2. Canada
            12.2.3. Mexico
     12.3. Market Size (USD Million) Forecast for North America 2020-2027

13. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

     13.1. Introduction
     13.2. Regional Market Trends
     13.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            13.3.1. Brazil
            13.3.2. Venezuela
            13.3.3. Argentina
            13.3.4. Rest of Latin America
     13.4. Market Size (USD Million) Forecast for Latin America 2020-2027

14. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

     14.1. Introduction
     14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
           14.2.1. Germany           
           14.2.2. U.K
           14.2.3. France
           14.2.4. Italy
           14.2.5. Spain
           14.2.6. Russia
           14.2.7. Poland
           14.2.8. Switzerland
           14.2.9. Rest of Western Europe
       14.3. Market Size (USD Million) Forecast for Europe 2020-2027

15. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 

        15.1. Introduction
        15.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
            15.2.1. Japan
            15.2.2. China
            15.2.3. Singapore
            15.2.4. India
            15.2.5. Australia and New Zealand
            15.2.6. ASEAN
            15.2.7. South Korea
            15.2.8. Rest of Asia Pacific
        15.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027

16. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)

        16.1. Introduction
        16.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
             16.2.1. Saudi Arabia
             16.2.2. UAE
             16.2.3. South Africa
             16.2.4. Egypt
        16.3. Market Size (USD Million) Forecast for MEA 2020-2027

17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

         17.1 ALERE       
                17.1.1. Company Overview
                17.1.2. Product Portfolio
                17.1.3. SWOT Analysis
                17.1.4. Financial Overview
                17.1.5. Strategic Overview
         17.2 DRAGERWERK
                17.2.1. Company Overview
                17.2.2. Product Portfolio
                17.2.3. SWOT Analysis
                17.2.4. Financial Overview
                17.2.5. Strategic Overview
         17.3 LABCORP
                17.3.1. Company Overview
                17.3.2. Product Portfolio
                17.3.3. SWOT Analysis
                17.3.4. Financial Overview
                17.3.5. Strategic Overview
         17.4 QUEST DIAGNOSTICS
                17.4.1. Company Overview
                17.4.2. Product Portfolio
                17.4.3. SWOT Analysis
                17.4.4. Financial Overview
                17.4.5. Strategic Overview
         17.5 ALFA SCIENTIFIC DESIGNS
                17.5.1. Company Overview
                17.5.2. Product Portfolio
                17.5.3. SWOT Analysis
                17.5.4. Financial Overview
                17.5.5. Strategic Overview
          17.6 LIFELOC
                17.6.1. Company Overview
                17.6.2. Product Portfolio
                17.6.3. SWOT Analysis
                17.6.4. Financial Overview
                17.6.5. Strategic Overview
         17.7 MPD INC.
                17.7.1. Company Overview
                17.7.2. Product Portfolio
                17.7.3. SWOT Analysis
                17.7.4. Financial Overview
                17.7.5. Strategic Overview
         17.8 ORASURE
                17.8.1. Company Overview
                17.8.2. Product Portfolio
                17.8.3. SWOT Analysis
                17.8.4. Financial Overview
                17.8.5. Strategic Overview
         17.9 OMEGA LABORATORIES
                17.9.1. Company Overview
                17.9.2. Product Portfolio
                17.9.3. SWOT Analysis
                17.9.4. Financial Overview
                17.9.5. Strategic Overview
         17.10 PREMIER BIOTECH
                17.10.1. Company Overview
                17.10.2. Product Portfolio
                17.10.3. SWOT Analysis
                17.10.4. Financial Overview
                17.10.5. Strategic Overview
        17.11 PSYCHEMEDICS
                17.11.1. Company Overview
                17.11.2. Product Portfolio
                17.11.3. SWOT Analysis
                17.11.4. Financial Overview
                17.11.5. Strategic Overview
         17.12 ROCHE
                17.12.1. Company Overview
                17.12.2. Product Portfolio
                17.12.3. SWOT Analysis
                17.12.4. Financial Overview
                17.12.5. Strategic Overview
         17.13 SHIMADZU
                17.13.1. Company Overview
                17.13.2. Product Portfolio
                17.13.3. SWOT Analysis
                17.13.4. Financial Overview
                17.13.5. Strategic Overview
         17.14 SIEMENS HEALTHINEERS
                17.14.1. Company Overview
                17.14.2. Product Portfolio
                17.14.3. SWOT Analysis
                17.14.4. Financial Overview
                17.14.5. Strategic Overview
    17.15 THERMO FISHER SCIENTIFIC
                17.15.1. Company Overview
                17.15.2. Product Portfolio
                17.15.3. SWOT Analysis
                17.15.4. Financial Overview
                17.15.5. Strategic Overview

18. FutureWise SME key takeaway points for Client

Tables

Figures